Global Glabridin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Glabridin market size was valued at US$ 35.7 million in 2024 and is forecast to a readjusted size of USD 60.6 million by 2031 with a CAGR of 6.7% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Glabridin is a naturally occurring flavonoid primarily extracted from the roots of Glycyrrhiza glabra (licorice). Renowned for its potent antioxidant and anti-inflammatory properties, glabridin is often incorporated into cosmetic formulations and skincare products to help brighten skin tone, reduce hyperpigmentation, and protect against oxidative stress. Beyond its dermatological benefits, ongoing research also investigates glabridin’s potential roles in metabolic health and inflammation management. Its efficacy and versatility, coupled with a relatively limited global supply, make glabridin a high-value active ingredient in both the personal care and nutraceutical industries.
The global Glabridin market shows a strong presence in Asia-Pacific, particularly driven by the high demand for skin-whitening products in countries such as China, South Korea, and Japan. In these markets, consumers prioritize natural and plant-derived actives, making Glabridin an attractive ingredient. Europe and North America also demonstrate steady growth, supported by a rising trend toward clean-label cosmetics and heightened awareness of the potential benefits of licorice root extracts. Meanwhile, emerging markets in Latin America and the Middle East are gradually embracing Glabridin-based formulations as consumer preferences shift toward safe and effective natural solutions.
Leading companies in the Glabridin sector include specialized botanical extract manufacturers and major cosmetic ingredient suppliers. These enterprises often invest heavily in research and development to refine extraction technologies—such as supercritical CO₂—and ensure high purity and consistent active content. Smaller, niche players also operate in the market, focusing on cost-effective or custom-formulated Glabridin extracts for targeted applications. Overall competition is shaped by product quality, supply-chain reliability, and brand recognition, with top manufacturers securing partnerships with global cosmetic brands seeking proven whitening and antioxidant solutions. The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
This report is a detailed and comprehensive analysis for global Glabridin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glabridin market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Glabridin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Glabridin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Glabridin market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glabridin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glabridin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, Hangzhou Lingeba Technology, Shaanxi Huatai Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glabridin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Up to 20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Market segment by Application
Creams and Lotions
Masks
Sunscreen Products
Others
Major players covered
Sabinsa
Mafco
Maruzen Pharmaceuticals
Hyundai Bioland
Shanghai OLI
Lepro Herbals
Gansu Fanzhi Pharmaceutical
Qinghai Lake Pharmaceutical
Hangzhou Lingeba Technology
Shaanxi Huatai Bio
Huzhou Ouli Biological Technology
Plamed Green Science Group
Xi'an Zhongying
Huaian Brothers Biotechnology
Alchem International
Ambe Phytoextracts
Sunpure Extracts
Novel Nutrientss
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glabridin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glabridin, with price, sales quantity, revenue, and global market share of Glabridin from 2020 to 2025.
Chapter 3, the Glabridin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glabridin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glabridin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glabridin.
Chapter 14 and 15, to describe Glabridin sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Glabridin is a naturally occurring flavonoid primarily extracted from the roots of Glycyrrhiza glabra (licorice). Renowned for its potent antioxidant and anti-inflammatory properties, glabridin is often incorporated into cosmetic formulations and skincare products to help brighten skin tone, reduce hyperpigmentation, and protect against oxidative stress. Beyond its dermatological benefits, ongoing research also investigates glabridin’s potential roles in metabolic health and inflammation management. Its efficacy and versatility, coupled with a relatively limited global supply, make glabridin a high-value active ingredient in both the personal care and nutraceutical industries.
The global Glabridin market shows a strong presence in Asia-Pacific, particularly driven by the high demand for skin-whitening products in countries such as China, South Korea, and Japan. In these markets, consumers prioritize natural and plant-derived actives, making Glabridin an attractive ingredient. Europe and North America also demonstrate steady growth, supported by a rising trend toward clean-label cosmetics and heightened awareness of the potential benefits of licorice root extracts. Meanwhile, emerging markets in Latin America and the Middle East are gradually embracing Glabridin-based formulations as consumer preferences shift toward safe and effective natural solutions.
Leading companies in the Glabridin sector include specialized botanical extract manufacturers and major cosmetic ingredient suppliers. These enterprises often invest heavily in research and development to refine extraction technologies—such as supercritical CO₂—and ensure high purity and consistent active content. Smaller, niche players also operate in the market, focusing on cost-effective or custom-formulated Glabridin extracts for targeted applications. Overall competition is shaped by product quality, supply-chain reliability, and brand recognition, with top manufacturers securing partnerships with global cosmetic brands seeking proven whitening and antioxidant solutions. The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
This report is a detailed and comprehensive analysis for global Glabridin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glabridin market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Glabridin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Glabridin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2020-2031
Global Glabridin market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glabridin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glabridin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, Hangzhou Lingeba Technology, Shaanxi Huatai Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glabridin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Up to 20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Market segment by Application
Creams and Lotions
Masks
Sunscreen Products
Others
Major players covered
Sabinsa
Mafco
Maruzen Pharmaceuticals
Hyundai Bioland
Shanghai OLI
Lepro Herbals
Gansu Fanzhi Pharmaceutical
Qinghai Lake Pharmaceutical
Hangzhou Lingeba Technology
Shaanxi Huatai Bio
Huzhou Ouli Biological Technology
Plamed Green Science Group
Xi'an Zhongying
Huaian Brothers Biotechnology
Alchem International
Ambe Phytoextracts
Sunpure Extracts
Novel Nutrientss
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glabridin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glabridin, with price, sales quantity, revenue, and global market share of Glabridin from 2020 to 2025.
Chapter 3, the Glabridin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glabridin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glabridin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glabridin.
Chapter 14 and 15, to describe Glabridin sales channel, distributors, customers, research findings and conclusion.
Table of Contents
131 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Glabridin by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
